| Diagnostic accuracy of blood-based biomarkers for pancreatic cancer: a systematic review and meta-analysis LE Kane, GS Mellotte, E Mylod, RM O'Brien, F O'Connell, CE Buckley, ... Cancer research communications 2 (10), 1229-1243, 2022 | 33 | 2022 |
| Natural killer cell therapy: A new frontier for obesity-associated cancer E Mylod, J Lysaght, MJ Conroy Cancer Letters 535, 215620, 2022 | 19 | 2022 |
| Tissue distribution of γδ T cell subsets in oesophageal adenocarcinoma AM Melo, E Mylod, V Fitzgerald, NE Donlon, DM Murphy, EK Foley, ... Clinical Immunology 229, 108797, 2021 | 14 | 2021 |
| Fractalkine elicits chemotactic, phenotypic, and functional effects on CX3CR1+ CD27− NK cells in obesity-associated cancer E Mylod, AM Melo, NE Donlon, M Davern, A Bhardwaj, JV Reynolds, ... The Journal of Immunology 207 (4), 1200-1210, 2021 | 12 | 2021 |
| The impact of esophageal oncological surgery on perioperative immune function; implications for adjuvant immune checkpoint inhibition NE Donlon, M Davern, AD Sheppard, F O’Connell, MR Dunne, C Hayes, ... Frontiers in Immunology 13, 823225, 2022 | 10 | 2022 |
| The omentum in obesity-associated cancer: A hindrance to effective natural killer cell migration towards tumour which can be overcome by CX3CR1 antagonism E Mylod, F O’Connell, NE Donlon, C Butler, JV Reynolds, J Lysaght, ... Cancers 14 (1), 64, 2021 | 9 | 2021 |
| Energy metabolism, metabolite, and inflammatory profiles in human ex vivo adipose tissue are influenced by obesity status, metabolic dysfunction, and treatment regimes in … F O’Connell, E Mylod, NE Donlon, AB Heeran, C Butler, A Bhardwaj, ... Cancers 15 (6), 1681, 2023 | 5 | 2023 |
| Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells M Davern, D Bracken-Clarke, NE Donlon, AD Sheppard, FO Connell, ... Journal of Cancer Research and Clinical Oncology 149 (9), 6583-6599, 2023 | 3 | 2023 |
| PD-1 blockade attenuates surgery-mediated immunosuppression and boosts Th1 immunity perioperatively in oesophagogastric junctional adenocarcinoma M Davern, C Gaughan, F O’Connell, B Moran, E Mylod, AD Sheppard, ... Frontiers in Immunology 14, 1150754, 2023 | 3 | 2023 |
| Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses E Mylod, E McKenna, M Davern, MP Barr, NE Donlon, BAS Bibby, ... Clinical and Experimental Medicine 23 (2), 411-425, 2023 | 3 | 2023 |
| Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses J Moran, E Mylod, LE Kane, C Marion, E Keenan, M Mekhaeil, J Lysaght, ... Pharmaceutics 15 (2), 360, 2023 | 2 | 2023 |
| Real-time ex vivo monitoring of NK cell migration toward obesity-associated oesophageal adenocarcinoma following modulation of CX3CR1 E Mylod, F O’Connell, NE Donlon, M Davern, C Marion, C Butler, ... Scientific Reports 14 (1), 4017, 2024 | 1 | 2024 |
| Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development LE Kane, GS Mellotte, E Mylod, P Dowling, S Marcone, C Scaife, ... Scientific Reports 15 (1), 129, 2025 | | 2025 |
| Assessing immune checkpoints on NK cells and the potential for immune checkpoint inhibition to reverse NK cell exhaustion in Metastatic Melanoma Patients J Behan, E Mylod, C Gardiner, F Kelleher EUROPEAN JOURNAL OF IMMUNOLOGY 54, 791-791, 2024 | | 2024 |
| Tumor-treating fields increase cytotoxic degranulation of natural killer cells against cancer cells E Mylod, G Conlon, EPW Jenkins, GG Malliaras, CM Gardiner Cell Reports Physical Science 5 (8), 2024 | | 2024 |
| Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma M Davern, C O’Donovan, NE Donlon, E Mylod, C Gaughan, A Bhardwaj, ... Biomedicines 12 (4), 819, 2024 | | 2024 |
| Ph. D. Surgery E Mylod Surgery, 2023 | | 2023 |
| Measuring Immune Cell Movement Toward the Soluble Microenvironment of Human Tissues Using a Boyden Chamber-Based Migration Assay E Mylod, J Lysaght, MJ Conroy Cancer Cell Culture: Methods and Protocols, 231-240, 2023 | | 2023 |
| Exploring the immune-metabolic mechanisms of adipose tissue in oesophageal adenocarcinoma F O'Connell, E Mylod, AB Heeran, NE Donlon, M Davern, C Butler, ... Cancer Research 82 (12_Supplement), 1990-1990, 2022 | | 2022 |
| Establishment of a novel multi-omic biomarker panel in cyst fluid and blood for stratifying patient risk of pancreatic cancer LE Kane, GS Mellotte, RG Lyons, E Mylod, S Marcone, PF Ridway, ... Cancer Research 82 (12_Supplement), 3381-3381, 2022 | | 2022 |
